Imaging Biometrics Limited IBAI

Imaging Biometrics Ltd (LSE:IBAI, FRA:5Y1) has published positive Phase 1 results for its oral gallium maltolate treatment in recurrent glioblastoma, with the drug found safe and well tolerated at all dose levels. One patient has now been on treatment for more than 38 months, and the company is reactivating its Expanded Access Programme for up to 20 additional patients. Rome Resources Plc (AIM:RMR) is launching its first field programme as operator at its New Brunswick tin-tungsten-indium project in Canada this week, with more than 500 samples planned across three priority targets. The company

KEFI Gold and Copper PLC (AIM:KEFI) has added a US$20 million equity-ranking royalty to fund its Tulu Kapi gold project in Ethiopia. It says the US$340 million package is now covered, with contractors mobilised and ground broken. Pan African Resources PLC (AIM:PAF, JSE:PAN) expects a sharp jump in half-year earnings. EPS is seen at over 7 US cents, helped by higher gold prices and 51% more production. Seeing Machines Ltd (AIM:SEE, OTC:SEEMF, FRA:M2Z) produced nearly 580,000 vehicles with its driver-monitoring systems in the second quarter of its 2026 financial year. It says demand is building